1. Home
  2. RAPT vs MKZR Comparison

RAPT vs MKZR Comparison

Compare RAPT & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • MKZR
  • Stock Information
  • Founded
  • RAPT 2015
  • MKZR 2012
  • Country
  • RAPT United States
  • MKZR United States
  • Employees
  • RAPT N/A
  • MKZR N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • MKZR
  • Sector
  • RAPT Health Care
  • MKZR
  • Exchange
  • RAPT Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • RAPT 498.4M
  • MKZR 10.3M
  • IPO Year
  • RAPT 2019
  • MKZR N/A
  • Fundamental
  • Price
  • RAPT $33.12
  • MKZR $5.30
  • Analyst Decision
  • RAPT Strong Buy
  • MKZR
  • Analyst Count
  • RAPT 8
  • MKZR 0
  • Target Price
  • RAPT $46.75
  • MKZR N/A
  • AVG Volume (30 Days)
  • RAPT 507.9K
  • MKZR 27.5K
  • Earning Date
  • RAPT 11-11-2025
  • MKZR 11-11-2025
  • Dividend Yield
  • RAPT N/A
  • MKZR 18.87%
  • EPS Growth
  • RAPT N/A
  • MKZR N/A
  • EPS
  • RAPT N/A
  • MKZR N/A
  • Revenue
  • RAPT N/A
  • MKZR $21,294,932.00
  • Revenue This Year
  • RAPT N/A
  • MKZR N/A
  • Revenue Next Year
  • RAPT N/A
  • MKZR N/A
  • P/E Ratio
  • RAPT N/A
  • MKZR N/A
  • Revenue Growth
  • RAPT N/A
  • MKZR 21.25
  • 52 Week Low
  • RAPT $5.67
  • MKZR $3.89
  • 52 Week High
  • RAPT $42.39
  • MKZR $55.00
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 74.53
  • MKZR 49.23
  • Support Level
  • RAPT $25.50
  • MKZR $5.14
  • Resistance Level
  • RAPT $42.39
  • MKZR $5.50
  • Average True Range (ATR)
  • RAPT 3.80
  • MKZR 0.37
  • MACD
  • RAPT -0.07
  • MKZR -0.03
  • Stochastic Oscillator
  • RAPT 48.89
  • MKZR 33.34

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: